Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity-Reference-Cited by-同舟云学术

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity

Published:2013-11-27 Issue:1 Volume:8 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Shelan Mohamed,Abo-Madyan Yasser,Welzel Grit,Bolenz Christian,Kosakowski Julia,Behnam Nadim,Wenz Frederik,Lohr Frank

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-8-276.pdf

Reference21 articles.

1. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H: Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 2002, 167: 117-122. 10.1016/S0022-5347(05)65394-3

2. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989, 141: 873-879.

3. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, et al.: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009, 181: 956-962. 10.1016/j.juro.2008.11.032

4. Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S, Willich N, Semjonow A, Souchon R, Stockle M, et al.: Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009, 27: 2924-2930. 10.1200/JCO.2008.18.9563

5. Resnick MJ, Cookson MS: Positive surgical margins at radical prostatectomy: much ado about nothing? Urol Oncol 2013, 31: 285-287. 10.1016/j.urolonc.2011.12.005

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility study of manual dose escalation method with normal tissue complication probability in radiation dose escalation for prostate cancer;Journal of the Korean Physical Society;2023-01-03

2. An investigation of oxygen enhancement ratio modeling for proton dose calculation;Journal of the Korean Physical Society;2022-09-21

3. Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data;World Journal of Clinical Oncology;2022-07-24

4. Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer—A Risk-Adjusted, Matched-Pair Analysis;Cancers;2022-03-04

5. Study of the calculation of the oxygen enhancement ratio for a carbon ion beam with fraction and linear energy transfer using various survival models;Journal of the Korean Physical Society;2022-02-28